CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFR14A Other DEFR14A
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
Page 10 of 46 · 904 filings